SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,692.16 809.34
(1.66%)

Dow Jones

7,235.98 79.03
(1.10%)

Hang Seng

59,153.23 -764.23
(-1.28%)

Nikkei 225

10,371.76 158.65
(1.55%)

Forex

USD-INR

94.79 0.27
(0.29%)

EUR-INR

110.85 0.20
(0.18%)

GBP-INR

127.93 0.23
(0.18%)

JPY-INR

0.59 0.00
(-0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Medicamen Biotech Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531146

INE646B01010

200.5802003

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MEDICAMEQ

38.91

343.55

EPS(TTM)

Face Value()

Div & Yield %

6.51

0.37

Back

Arunjyoti Bio Ventures reports standalone net loss of Rs 1.23 crore in the September 2025 quarter

Nov 03,2025

Net Loss of Arunjyoti Bio Ventures reported to Rs 1.23 crore in the quarter ended September 2025 as against net loss of Rs 0.22 crore during the previous quarter ended September 2024. Sales declined 15.91% to Rs 5.34 crore in the quarter ended September 2025 as against Rs 6.35 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5.34	6.35	-16
OPM %	4.68	12.13	-
PBDT	-0.25	0.21	PL
PBT	-1.08	-0.53	-104
NP	-1.23	-0.22	-459

76,913.50 -582.86 ( -0.75%)

49,692.16 809.34 (1.66%)

7,235.98 79.03 (1.10%)

59,153.23 -764.23 (-1.28%)

10,371.76 158.65 (1.55%)

94.79 0.27 (0.29%)

110.85 0.20 (0.18%)

127.93 0.23 (0.18%)

0.59 0.00 (-0.01%)